SenesTech (NASDAQ:SNES) Now Covered by Analysts at StockNews.com

Analysts at StockNews.com started coverage on shares of SenesTech (NASDAQ:SNESGet Free Report) in a research note issued to investors on Thursday. The firm set a “sell” rating on the stock.

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $3.50 price target on shares of SenesTech in a research report on Tuesday, May 14th.

Read Our Latest Research Report on SenesTech

SenesTech Stock Down 2.0 %

Shares of NASDAQ SNES opened at $0.50 on Thursday. SenesTech has a twelve month low of $0.50 and a twelve month high of $14.04. The business has a fifty day simple moving average of $0.70 and a two-hundred day simple moving average of $0.83. The company has a quick ratio of 5.69, a current ratio of 6.91 and a debt-to-equity ratio of 0.03.

SenesTech (NASDAQ:SNESGet Free Report) last released its quarterly earnings data on Thursday, May 9th. The company reported ($0.36) earnings per share for the quarter, missing the consensus estimate of ($0.34) by ($0.02). SenesTech had a negative net margin of 545.82% and a negative return on equity of 181.46%. The firm had revenue of $0.42 million during the quarter, compared to the consensus estimate of $0.43 million. During the same quarter in the previous year, the firm earned ($15.85) earnings per share. Equities research analysts predict that SenesTech will post -1.1 earnings per share for the current fiscal year.

Institutional Investors Weigh In On SenesTech

A hedge fund recently bought a new stake in SenesTech stock. McAdam LLC bought a new stake in SenesTech, Inc. (NASDAQ:SNESFree Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 64,348 shares of the company’s stock, valued at approximately $44,000. McAdam LLC owned approximately 1.25% of SenesTech as of its most recent SEC filing. 5.19% of the stock is owned by hedge funds and other institutional investors.

About SenesTech

(Get Free Report)

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Read More

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.